Loading page
Loading page
Loading substance route
These combinations are considered extremely harmful and should always be avoided. Reactions to these drugs taken in combination are highly unpredictable and have a potential to cause death.
There is considerable risk of physical harm when taking these combinations, they should be avoided where possible.
These combinations are not usually physically harmful, but may produce undesirable effects, such as physical discomfort or overstimulation. Extreme use may cause physical health issues. Synergistic effects may be unpredictable. Care should be taken when choosing to use this combination.
Considered highly addictive with a high potential for abuse. The short-lasting euphoric effects (1-2 hours) encourage compulsive redosing while still intoxicated. Rapidly increases benzodiazepine cross-tolerance, making short-term use strongly advised.
Regular use leads to physical dependence with potentially life-threatening withdrawal. Discontinuation after prolonged use can cause dizziness, physical weakness, tremors, sleep disturbances, sweating, nausea, hallucinations, depression, and seizures. Gradual dose tapering under medical supervision is necessary; abrupt cessation is dangerous.
Likely has low toxicity relative to dose when used alone. However, it is potentially lethal when combined with other depressants such as alcohol, opioids, barbiturates, or GHB/GBL due to respiratory depression.
Paradoxical reactions including aggression, violent behavior, and suicidal behavior occur rarely in the general population (below 1% incidence). These effects occur with greater frequency in recreational abusers, individuals with mental disorders, children, and those on high-dosage regimens. Hallucinations may occur as a withdrawal symptom.
Has anticonvulsant properties during use (seizure suppression). However, there is an increased risk of seizures following discontinuation, particularly after heavy or long-term use. Paradoxically, some benzodiazepines can cause seizures in epileptics. Substances that lower seizure threshold should be avoided during withdrawal.
Flualprazolam was first synthesized in 1976 as part of broader benzodiazepine research, representing the triazolo analog of fludiazepam and structurally related to alprazolam as its 2'-fluoro derivative. Despite its early synthesis, the compound was never developed for pharmaceutical use and…
UN Convention on Psychotropic Substances 1971 (Schedule II) - added March 2020
Listed under Anlage II of the Betäubungsmittelgesetz (Narcotics Act) as of January 21, 2021. This schedule designates it as a marketable controlled narcotic requiring prescription authorization.
Classified as a controlled drug under national drug legislation. Possession, production, supply, and importation are all prohibited.
Designated as a Schedule I controlled substance effective January 23, 2023. Classified as having high potential for abuse with no currently accepted medical use in treatment.
Placed under the IV-P group of controlled psychotropic substances as of March 11, 2021. Ownership, possession, and sale are prohibited under Polish law.
Controlled under the blanket ban of the Psychoactive Substances Act rather than scheduled under the Misuse of Drugs Act. Production, supply, and possession with intent to supply carry criminal penalties.
11 sources cited